nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antioxidant hypocholesterolemic agents
|
|
|
1996 |
1 |
6 |
p. 261-262 2 p. |
artikel |
2 |
Combinatorial chemistry
|
Terrett, Nick |
|
1996 |
1 |
6 |
p. 266- 1 p. |
artikel |
3 |
Commercially valuable catalytic antibodies: the life to come
|
Martin, Mark T. |
|
1996 |
1 |
6 |
p. 239-247 9 p. |
artikel |
4 |
Corrigendum
|
|
|
1996 |
1 |
6 |
p. 230- 1 p. |
artikel |
5 |
Cystic fibrosis: new strategies for drug therapy
|
Wallace, Robert W. |
|
1996 |
1 |
6 |
p. 225-226 2 p. |
artikel |
6 |
Dopamine D3 receptor antagonists
|
|
|
1996 |
1 |
6 |
p. 261- 1 p. |
artikel |
7 |
Drug discovery and VDDCs
|
Lightfoot, Gary |
|
1996 |
1 |
6 |
p. 255-260 6 p. |
artikel |
8 |
Emerging molecular targets
|
|
|
1996 |
1 |
6 |
p. 264- 1 p. |
artikel |
9 |
Focus on fungal infections
|
Hunter, Pamela A. |
|
1996 |
1 |
6 |
p. 227-228 2 p. |
artikel |
10 |
Furberg goes over the top on calcium channel antagonists
|
Jack, David B. |
|
1996 |
1 |
6 |
p. 225- 1 p. |
artikel |
11 |
Getting that hit: 3D database searching in drug discovery
|
Manallack, David T. |
|
1996 |
1 |
6 |
p. 231-238 8 p. |
artikel |
12 |
HIV-1 protease inhibitor
|
|
|
1996 |
1 |
6 |
p. 261- 1 p. |
artikel |
13 |
HTS in Drug Discovery Today
|
|
|
1996 |
1 |
6 |
p. 230- 1 p. |
artikel |
14 |
Kinetic resolution using nonenzymatic acylating agents
|
|
|
1996 |
1 |
6 |
p. 263- 1 p. |
artikel |
15 |
Metabotropic glutamate receptor antagonist
|
|
|
1996 |
1 |
6 |
p. 262- 1 p. |
artikel |
16 |
[No title]
|
Eaton, Bruce E. |
|
1996 |
1 |
6 |
p. 230- 1 p. |
artikel |
17 |
[No title]
|
King, Frank D. |
|
1996 |
1 |
6 |
p. 229- 1 p. |
artikel |
18 |
Novartis who? an update
|
Hughes, David |
|
1996 |
1 |
6 |
p. 228- 1 p. |
artikel |
19 |
Novel antidepressant agent
|
|
|
1996 |
1 |
6 |
p. 261- 1 p. |
artikel |
20 |
Novel fungal phospholipase D inhibitors
|
|
|
1996 |
1 |
6 |
p. 262- 1 p. |
artikel |
21 |
Orally active squalene synthase inhibitor
|
|
|
1996 |
1 |
6 |
p. 261- 1 p. |
artikel |
22 |
Phosphotyrosine isosteres
|
|
|
1996 |
1 |
6 |
p. 263- 1 p. |
artikel |
23 |
Scots search for slimmers' holy grail
|
Jack, David B. |
|
1996 |
1 |
6 |
p. 226- 1 p. |
artikel |
24 |
Selective PGD2 receptor agonists
|
|
|
1996 |
1 |
6 |
p. 262- 1 p. |
artikel |
25 |
Solution-phase synthesis in combinatorial chemistry: Applications in drug discovery
|
Storer, Richard |
|
1996 |
1 |
6 |
p. 248-254 7 p. |
artikel |
26 |
Synthesis of 2′-deoxy-2′substituted-4′-thiocytidines
|
Wallace, Roben W. |
|
1996 |
1 |
6 |
p. 264- 1 p. |
artikel |
27 |
Synthesis of pyridine derivatives
|
|
|
1996 |
1 |
6 |
p. 263- 1 p. |
artikel |
28 |
Therapeutic profile: NK1 receptor antagonists
|
|
|
1996 |
1 |
6 |
p. 265-266 2 p. |
artikel |
29 |
VanX inhibitors
|
|
|
1996 |
1 |
6 |
p. 262- 1 p. |
artikel |